Pathway22.ai is pioneering the intersection of quantum-secured technology and clinical intelligence to redefine longevity healthcare. We empower healthcare providers to deliver highly personalized, preventative care, transforming the way data is protected, shared, and monetized while ensuring complete patient privacy. Currently in pre-seed stage, we're actively engaging forward-thinking clinics and laboratories for an exclusive pilot program. Join us in shaping the future of longevity medicine—securely, innovatively, and profoundly.
| Website | https://www.pathway22.ai |
| Employees | 3 (1 on RocketReach) |
| Founded | 2024 |
| Industry | Technology, Information and Internet |
Looking for a particular Pathway22.ai employee's phone or email?
Isobel Glanville-Pearl is the Founder and CEO of Pathway22.ai.
1 people are employed at Pathway22.ai.
Pathway22.ai is based in London, England.